1[1]Albert CM, Hennekens CH, O' Donnell CJ, et al. Fish consumption and risk of sudden death [ J ]. JAMA,1998, 279: 23 - 282
2[2]Hu FB, Bronner L, Willett WC, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women[J]. JAMA, 2002, 287:1815 - 1821
3[3]Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrance levels of long- chain n - 3polyunsaturated fatty acids and the risk of primary cardiac arrest[J ]. JAMA, 1995, 274:1363 - 1367
4[4]Weber PC, Fischer S, yon Schacky, et al. The conversion of dietary eicosapentaenic acid to prostaglandins and leukotrienes in man[J]. Prog Lipid Res, 1986, 25:273 - 276
5[5]Burr M, Fehily AM, Gillbert JF, et al. Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction: Diet And Reinfarction Trial (DART)[J]. Lancet, 1989, 334:757 - 761
6[6]de Lorgeri M, Renaud S, Mamelle N, et al. Mediterrannean alpha- linolenic acid - rich diet in secondary prevention of coronary heart disease [ J ]. Lancet, 1994,343:1454 - 1459
7[7]de Lorgeri M, Salen P, Martin J - L, et al. Meditermean diet, tranditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Heart Study[J]. Circulation, 1999, 99: 779 - 785
8[8]GISSI - Prevenzione Investigators. Dietary supplementation with n - 3polyunsaturated fatty acids and vitamine E after myocardial infarction: results of the GISSI - Prevenzione trial[J]. Lancet, 1999, 354:447 - 455
9[9]Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by n - 3 polyunsaturated fatty acids after myocardial infarction: time - course analysis of the results of the Gruppo Italiano per lo Studio dela Sopravvivena nell' s Infarto Miocardico(GISSI) - Prevenzione. Circulation, 2002, 105:1897 - 1903
10[10]Singh RB, Niaz MA, Sharma JP, et al. Randomized double - blind, placebo - controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival[J]. Cardiovasc Drugs Ther, 1997, 11: 485 - 491
